Zenas BioPharma, Inc. (ZBIO)
21.57
+1.79
(+9.05%)
USD |
NASDAQ |
Jan 13, 16:00
21.40
-0.17
(-0.79%)
After-Hours: 20:00
Zenas BioPharma Free Cash Flow: -158.56M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Royalty Pharma Plc | 1.048B |
| Nektar Therapeutics | -190.35M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.12M |
| Cash from Investing (Quarterly) | 40.04M |
| Cash from Financing (Quarterly) | 72.62M |
| Free Cash Flow Per Share (Quarterly) | -0.9755 |
| Free Cash Flow to Equity (Quarterly) | -40.92M |
| Free Cash Flow to Firm (Quarterly) | -41.12M |
| Free Cash Flow Yield | -17.54% |